Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer Meeting Abstract
| Authors: | Grisham, R. N.; Giri, D. D.; McDonnell, A.; Iasonos, A.; Zhou, Q.; Li, K.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Aghajanian, C. |
| Abstract Title: | Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer |
| Meeting Title: | 51st Annual Meeting of the Society of Gynecologic Oncology (SGO) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 159 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Mar 28-31 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | 23 |
| Language: | English |
| ACCESSION: | WOS:000579556200043 |
| DOI: | 10.1016/j.ygyno.2020.06.046 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 43 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
184Giri -
201Zamarin -
253Zhou -
362Iasonos -
169Grisham -
271O'Cearbhaill -
607Aghajanian -
31Girshman -
4Li
Related MSK Work